Avanir Pharmaceuticals Inc $11.04

down -0.64


19/9/2014 04:00 PM  |  NASDAQ : AVNR  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get AVNR Trend Analysis - it has outperformed the S&P 500 by 138%

Partner Headlines

  1. Morning Market Losers

    Benzinga
  2. Benzinga's Top #PreMarket Losers

    Benzinga
  3. Avanir Pharmaceuticals

    IBD
  4. Technology Stocks Down As Rest Of The Market Starts Week Flat

    Benzinga
  5. Terex Falls After Lowered Earnings Forecast; Avanir Pharmaceuticals Shares ...

    Benzinga
  6. NASDAQ Tumbles 1.1%; Alere Shares Surge Following Proposed $46/Share Offer

    Benzinga
  7. Midday Gainers From September 15 - RadioShack Corporation, Rewalk Robotics ...

    Benzinga
  8. Markets Fall; Cognizant To Acquire TriZetto For $2.7 Billion

    Benzinga
  9. Benzinga's Volume Movers

    Benzinga
  10. Morning Market Movers

    Benzinga
  11. Avanir Pharmaceuticals Announces Positive Phase II Trial Results For AVP-923 ...

    Benzinga
  12. Stocks Hitting 52-Week Highs

    Benzinga
  13. Events for the Week of Sept. 8-12

    Benzinga
  14. U.S. Stocks Rise; Palo Alto Networks Shares Surge On Upbeat Revenue

    Benzinga
  15. Avanir Pharmaceuticals Announces Initiation Of Phase II Study of AVP-786 ...

    Benzinga
  16. Avanir Pharmaceuticals Announces FDA Acceptance Of IND For AVP-786, Used ...

    Benzinga
  17. AVANIR Pharma Offers Three Presentations for AVP-825 for Acute Treatment ...

    Benzinga
  18. Morning Market Movers

    Benzinga
  19. Benzinga's Top #PreMarket Gainers

    Benzinga
  20. Benzinga's Top #PreMarket Gainers

    Benzinga
  21. Avanir Pharmaceuticals Announces Data Presentation of Central Nervous System ...

    Benzinga
  22. Morning Market Movers

    Benzinga
  23. UPDATE: Avanir Pharmaceuticals Announces Acceptance of New Drug Application ...

    Benzinga
  24. Avanir Pharmaceuticals Announces Appointment of Mark Corrigan to Board ...

    Benzinga
  25. Avanir Pharmaceuticals Announces Submission of New Drug Application for ...

    Benzinga
  26. Mid-Afternoon Market Update: Markets Falling as Smith & Wesson Continues ...

    Benzinga
  27. Mid-Day Market Update: Smith & Wesson Gains On Upbeat Profit; LabCorp Shares ...

    Benzinga
  28. Mid-Morning Market Update: Markets Fall; Joy Global Profit Misses Estimates

    Benzinga
  29. Morning Market Losers

    Benzinga
  30. Benzinga's Top #PreMarket Losers

    Benzinga
  31. Benzinga's Top Downgrades

    Benzinga
  32. Earnings Scheduled For December 10, 2013

    Benzinga
  33. Earnings Expectations For The Week Of December 9

    Benzinga
  34. Avanir Pharma Reports Enrollment of First Patient in Study of AVP-923

    Benzinga
  35. Mid-Afternoon Market Update: Apple Plummets Downwards As Markets Remain ...

    Benzinga
  36. Mid-Day Market Update: Dow Jumps More Than 1%; Apple Shares Drop

    Benzinga
  37. Mid-Morning Market Update: Markets Surge; Packaging Corp To Acquire Boise ...

    Benzinga
  38. Benzinga's Top Pre-Market Gainers

    Benzinga
  39. Market Wrap For Friday, September 13: Markets Erase August Losses On Light ...

    Benzinga
  40. Mid-Afternoon Market Update: Markets Green as Avanir Plummets

    Benzinga
  41. Benzinga's Top Pre-Market Losers

    Benzinga
  42. Avanir Shares Rebound As Analysts Offer Defense On Heels of 13% Drop

    Benzinga
  43. Wedbush Reiterates Outperform on Avanir Pharmaceuticals on Buying Opportunity ...

    Benzinga
  44. Investors In Avanir Cheer As Piper Jaffray Lifts Target On Stock Sharply ...

    Benzinga
  45. Benzinga's Top Pre-Market Gainers

    Benzinga
  46. Avanir Pharma Reports Publication of PRISM Registry Findings

    Benzinga
  47. Mid-Day Market Update: Brocade Surges On Upbeat Results, Cree Shares Fall

    Benzinga
  48. Stocks Hitting 52-Week Highs

    Benzinga
  49. Mid-Morning Market Update: Markets Open Lower, Deere Posts Higher Q3 Profit

    Benzinga
  50. Avanir Pharma Reports Settlement of NUEDEXTA Patent Litigation with Sandoz

    Benzinga
Trading Center